Anticancer activity of honey and its phenolic components

Honey: Current Research and Clinical Applications

Volumn , Issue , 2012, Pages 39-60

  Jaganathan, Saravana Kumar ^a   Mandal, Mahitosh ^b  

^a PSNA COLLEGE OF ENGINEERING AND TECHNOLOGY   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895228284     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (71)

1. Sporn, M. B. and Newton, D. L. (1979). Chemoprevention of cancer with retinoids. Fed. Proc., 38, 2528-2534.
2. Kelloff, G. J. (2000). Perspectives on cancer chemoprevention research and drug development. Adv. Cancer Res., 78, 199-334.
3. Kelloff, G. J. and Boone, C. W. (1994). Cancer chemopreventive agents. Drug development status and future prospects I, J. Cell Biochem. (Suppl. 20). New York, NY: Wiley-Liss.
4. Kelloff, G. J., Hawk, E. T. and Sigman, C. C. (2004). Cancer Chemoprevention Volume 1: Promising Cancer Chemopreventive Agent, Totowa, NJ: Humana Press.
5. Ferguson, L. R. (1994). Antimutagens as cancer chemopreventive agents in the diet. Mutat. Res., 307, 395-410.
6. Ferguson, L. R., Philpott, M. and Karunasinghe, N. (2004). Dietary cancer and prevention using antimutagens. Toxicol.,198,147-159.
7. Surh, Y. J. (2003). Cancer chemoprevention with dietary phytochemicals. Nature Rev. Cancer, 3, 768-780.
8. Wollgast, J. and Anklam, E. (2000). Review on polyphenols in Theobroma cacao: changes in composition during the manufacture of chocolate and methodology for identification and quantification. Food Res. Int., 33, 423-447.
9. Madhavi, D. V., Despande, S. S., Salunkhe, D. K., Madhavi, D. L., Deshpande, S. S. and Salunkhe, D. K. (1996). Food Antioxidants. New York, NY: Marcel Dekker.
10. Food and Agriculture Organization. (1996). Agricultural Services Bulletin Food and Agriculture Organization. Rome. Italy.
11. Antony, S. M., Han, I. Y., Rieck, J. R. and Dawson, P. L. (2000). Antioxidative effect of maillard reaction products formed from honey at different reaction times. J. Agric. Food Chem., 48, 3985-3989.
12. Vit, P., Soler, C. and Toḿas-Barbeŕan, F. A. (1997). Profiles of phenolic compounds of Apis mellifera and Melipona spp. honeys from Venezuela. Unters Forsch. Lebensm. Z., 204, 43-47.
13. Cherchi, L., Spanedda, C., Tuberoso, C. and Cabras, P. (1994). Solid-phase extraction and HPLC determination of organic acid in honey. J. Chromat. A, 669, 59-64.
14. Davies, A. M. C. and Harris, R. G. (1982). Free amino acid analysis of honeys from England and Wales: application to determination of the geographical origin of honeys. J. Apic. Res., 21, 168-173.
15. White, J. W. (1975). Composition of honey. In Crane, E. (Ed.), Honey, a comprehensive survey. (pp. 157-206). London (UK): Bee Research Association and Chalfont St Peter.
16. Tan, S. T, Wilkins, A. L., Holland, P. T. and McGhie, T. K. (1989). Geographical discrimination of honeys though the employment of sugar patterns and common chemical quality parameters. J. Agri. Food Chem., 37, 1217-1221.
17. White, J. W. (1978). The protein content of honey. J. Apic. Res., 17, 234-238.
18. Amiot, M. J., Aubert, S., Gonnet, M. and Tacchini, M. (1989). Les composés phénoliques des miels: étude préliminaire surl identify cation et la quantifi cation par familles. Apidologie, 20, 115-125.
19. World Wide Wounds. Honey as a topical antibacterial agent for treatment of infected wounds. Last Modified. February 15, 2002. http://www.worldwidewounds.com /2001 /november/Molan/honey-as-topical-agent.html.
20. National Honey Board. Honey and Bees. Last accessed April 14, 2007. http://www.honey.com/consumers.
21. Todd, F. E. and Vansell, G. H. (1942). Pollen grains in nectar and honey. J. Econ. Entomol., 35, 728-731.
22. Jaganathan, S. K. and Mandal, M. (2009). Honey constituents and its apoptotic effect in colon cancer cells. J. Api. Prodcut. Api. Med. Sci.,1, 29-36.
23. Jaganathan, S. K. and Mandal, M. (2010). Involvement of non-protein thiols, mitochondrial dysfunction, reactive oxygen species and p53 in honey-induced apoptosis. Invest. New Drugs, 5, 624-633.
24. Jaganathan, S. K., Mondhe, D., Wani, Z. A., Pal, H. C. and Mandal, M. (2010). Effect of honey and eugenol on Ehrlich ascites and solid carcinoma. J. Biomed. Biotechnol., No. 989163.
25. Jaganathan, S. K. (2011). Can flavonoids from honey alter multidrug resistance? Med. Hypotheses, 76, 535-537.
26. Orsolic, N., Knezevi, A., Sver, L., Terzi, S., Hackenberger, B. K. and Basi, I. (2004). Influence of honey bee products on transplantable tumours. J. Vet. Compar. Oncology, 4, 216-226.
27. Tarek, S., Naoto, M., Mizuki, O., Kazunori, H., Koji, K., Toru, S. and Hideyuki, A. (2003). Antineoplastic activity of honey in an experimental bladder cancer implantation model: In vivo and in vitro studies. Int. J. Urol., 10, 213-219.
28. Gribel, N. V. and Pashinskii, V. G. (1990). The antitumor properties of honey Voprosi Onkologii J., 36, 704-709.
29. Cook, N. C. and Sammon, S. (1996). Flavonoids-Chemistry, metabolism, cardioprotective effects and dietary sources. Nutr. Biochem., 7, 66-76.
30. Catapano, A. L. (1997). Antioxidant effect of flavonoids. Angiology, 48, 39-44.
31. Loku, K., Tsushida, T., Takei, Y., Nakatani, N. and Terao, J. (1995). Antioxidant activity of quercitin monoglucosides in solution and phospholipid bilayers. Biochem. Biophys. Acta, 1234, 99-104.
32. Salah, N., Millar, N. J., Paganda, G., Tijburg, L., Bolwell, G. P. and Rice-Evans, C. (1995). Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys., 322, 339-346.
33. Serafin, M., Ghiselli, A. and Ferro-Luzzi, A. (1996). In vivo antioxidant effect of green and black tea in man. Eur. J. Clin. Nutr., 50, 28-32.
34. Vinson, J. A., Hao, Y., Su, X. and Zubik, L. (1998). Phenol antioxidant quantity and quality in foods: vegetables. J. Agric. Food Chem., 46, 3630-3634.
35. Bravo, L. (1998). Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev., 56, 317-333.
36. Ferreres, F., Blazquez, M. A., Gil, M. I. and Tomas-Barberan, F. A. (1994). Separation of honey flavonoids by micellar electrokinetic capillary chromatography. J. Chromat., 669, 268-274.
37. Ferreres, F., Juan, T., Perez-Arquillue, C., Herrera-Marteache, A., Garcia-Viguera, C. and Tomas-Barberan, F. (1998). Evaluation of pollen as a source of kaempferol in rosemary honey. J. Sci. Food Agric., 77, 506-510.
38. Tomas-Barberan, F. A., Martos, I., Ferreres, F., Radovic, B. S. and Anklam, E. (2001). HPLC flavonoid profiles as markers for the botanical origin of European unifloral honeys. J. Sci. Food Agric., 81, 485-496.
39. Cherchi, A., Spanedda, L., Tuberoso, C. and Cabras, P. (1994). Solid-phase extraction and HPLC determination of organic acid in honey J. Chromat., 669, 59-64.
40. Hirose, M., Takesada, Y., Tanaka, H., Tamano, S., Kato, T. and Shirai, T. (1998). Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4- methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi- organ carcinogenesis model. Carcinogenesis, 19, 207-212.
41. Rao, C. V., Desai, D., Simi, B., Kulkarni, N., Amin, S. and Reddy, B. S. (1993). Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res., 3, 4182-4188.
42. Rao, C. V., Desai, D., Kaul, B., Amin, S. and Reddy, B. S. (1992). Effect of caffeic acid esterson carcinogen-induced mutagenecity and human colon adenocarcinoma cell growth. Chem. Biol. Interact., 84, 277-290.
43. Huang, M. T., Ma. W., Yen, P., Xie, J. G., Han, J., Frenkel, K., Grunberger, D. and Conney, A. H. (1996). Inhibitory effects of caffeic acid phenethyl ester (CAPE) on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in mouse skin and the synthesis of DNA, RNA and protein in HeLa cells. Carcinogenesis, 17, 761-765.
44. Natarajan, K., Singh, S., Burke, T. R., Grunberger, D. and Aggarwal, B. B. (1996). Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. PNAS, 93, 9090-9095.
45. Lee, Y. J., Kuo, H. C., Chu, C. Y., Wang, C. J., Lin, W. C. and Tseng, T. H. (2003). Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochem. Pharmacol., 66, 2281-2289.
46. Chung, T. W., Moon, S. K., Chang, Y. C. and Ko, J. H. (2004). Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J., 80, 1670-1681.
47. Hwang, H. J., Park, H. J., Chung, H. J., Min, H. Y., Park, E. J., Hong, J. Y. and Lee, S. K. (2006). Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells. J. Nutr. Biochem., 17, 356- 362.
48. Nereadil, J; Veselska, R. and Slanina J. (2003). UVC protective effect of Caffeic acid on Normal and transformed skin cells in vitro. Folia Biol., 49, 197-202.
49. Staniforth, V., Chiu, L. Y. and Yang, N. S. (2006). Caffeic acid suppresses UVB radiation-induced expression of interleukin-10 and activation of mitogen-activated protein kinases in mouse. Carcinogenesis, 27, 1803-1811.
50. Weng, M. S., Ho, Y. S. and Lin, J. K. (2005). Chrysin induces G1 phase cell cycle arrest in C6 glioma cells though inducing p21Waf1/Cip1 expression: Involvement of p38 mitogen-activated protein kinase. Biochem. Pharmacol., 69, 1815-1827.
51. Woo, K. J., Jeong, Y. J., Park, J. W. and Kwona, T. K. (2004). Chrysin-induced apoptosis is mediated though caspase activation and Akt inactivation in U937 leukemia cells. Biophys. Biochem. Res. Comm., 325, 1215-1222.
52. Zheng, X., Meng, W. D., Xu, Y. Y., Cao, J. G. and Qing, F. L. (2003). Synthesis and Anticancer Effect of Chrysin Derivatives. Bioorg. Med. Chem. Lett., 13, 881-884.
53. Zhang, T., Chen, X., Qu, L., Wu, J., Cui, R. and Zhao, Y. (2004). Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells. Bioorg. Med. Chem., 12, 6097-6105.
54. Bestwick, S., and Milne, L. (2005). Influence of galangin on HL-60 cell proliferation and survival. Cancer. Lett, 243, 80-89.
55. Kang, T. B. and Liang, M. C. (1997). Studies on the inhibitory effects of quercetin on the growth of HL460 leukemia cells. Biochem. Pharmacol., 54, 1013-1018.
56. Csokay, B., Prajda, N., Weber, G. and Olah, E. (1997). Molecular mechanisms in the antiproliferative action of quercetin. Life Sci., 60, 2157-2163.
57. Robaszkiewicz, A., Balcerczyk, A. and Bartosz, G. (2006). Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol. Int., 31, 1245-1250.
58. Braganhol, E., Zamin; L. L., Canedo, A. D., Horn, F., Tamajusuku, A. S., Wink, M. R., Salbego, C. and Battastini, A. M. (2006). Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anti Cancer Drugs, 17, 663-671.
59. Indap, M. A., Radhika, S., Motiwale, L. and Rao, K. V. K. (2006). Antitumor activity and pharmacological Manipulations for increased therapeutic gains. Ind. J. Pharmaceut. Sci., 68, 465-469.
60. Choi, E. J., Bae, S. M. and Ahn, W. S. (2008). Antiproliferative effects of quercetin though cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Arch. Pharmcol. Res., 31, 1281-1285.
61. Hsu, Y. L., Kuo, P. L., Liu, C. F. and Lin, C. C. (2004). Acacetin-induced cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells. Cancer Lett., 212, 53-60.
62. Hsu, Y. L., Kuo, P. L., and Lin, C. C. (2003). Acacetin inhibits the proliferation of Hep G2 by blocking cell cycle progression and inducing apoptosis. Biochem. Pharmacol., 67, 823-829.
63. Leung, H. W., Lin, C. J., Hour, M. J.., Yang, W. H., Wang, M. Y. and Lee, H. Z. (2007). Kaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymes. Food Chem. Toxicol., 45, 2005-2013.
64. Bestwick, C. S., Milne, L. and Duthie, S. J. (2002). Kaempferol induced inhibition of HL-60 cell growth results from a heterogeneous response, dominated by cell cycle alterations. Chem. Biol. Interact., 170, 76-85.
65. Kumar, M. A., Nair, M., Hema, P. S., Mohan, J. and Santhoshkumar, T. R. (2006). Pinocembrin triggers Bax-dependent mitochondrial apoptosis in colon cancer cells. Mol. Carcinog,, 46, 231-241.
66. Santos, A. C., Uyemura S. A., Lopes, J. L., Bazon, J. N., Mingatto, E. F. and Curti, C. (1998). Effect of naturally occurring flavonoids on lipid peroxidation and membrane permeability transition in mitochondria. Free Radic. Biol. Med., 24, 1455-1461.
67. Wang, W., Heideman, L., Chung, C. S., Pelling, J. C, Koehler, K. J. and Birt, D. F. (2000). Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol. Carcinog., 28, 102-110.
68. Way, T. D., Kao, M. C. and Lin, J. K. (2004). Apigenin induces apoptosis though proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol-3'- kinase/Akt-dependent pathway. J. Biol. Chem., 279, 4479-4489.
69. Zheng, P. W., Chiang, L. C., Lin, C. C. (2005). Apigenin induced apoptosis though p53-dependent pathway in human cervical carcinoma cells. Life Sci., 76, 1367-1379.
70. Torkin, R., Lavoie, J. F., Kaplan, D. R. and Yeger, H. (2005). Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma. Mol. Cancer Ther., 4, 1-11.
71. Chiang, L. C., Ng, L. T., Lin, I. C., Kuo, P. L. and Lin, C. C. (2006). Antiproliferative effect of apigenin and its apoptotic induction in human Hep G2 cells. Cancer Lett., 237, 207-214.